theme: Drug Resistance/Sensitivity, Heterogeneity grantId: syn17084070 abstract: The goal of our U01 project to develop rational systems approaches to treat cancer. Small-cell lung cancer (SCLC) is arguably the most aggressive form of lung cancer, and while modern treatment strategies are initially highly effective, tumors quickly relapse, resistant to further therapies. grantName: Phenotype Transitions in Small Cell Lung Cancer - CA215845 grantType: U01 centerName: Phenotype Transitions in Small Cell Lung Cancer - CA215845 centerSite: http://grantome.com/grant/NIH/U01-CA215845-02 consortium: CSBC grantNumber: CA215845 institution: Vanderbilt University investigator: Vito Quaranta, Carlos F. Lopez fundingAgency: NCI teamProfileId: 3355675 keyInvestigators: Vito Quaranta, Carlos F. Lopez grantExternalSite: http://grantome.com/grant/NIH/U01-CA215845-02 syn17084071 syn17084072 syn17084073 syn21792695
Drop files to upload
Phenotype Transitions in Small Cell Lung Cancer - CA215845 page is loading…